Japan Tissue Engineering Co., Ltd.
7774.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.85 | 0.07 | -0.28 | -0.05 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | -213.07 | -100.40 | 76.74 | -163.12 |
| Quality | ||||
| ROIC | -2.40% | -4.35% | 2.52% | -2.16% |
| Gross Margin | 57.00% | 50.76% | 68.25% | 60.50% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -0.20% | 2.41% | 6.52% | 7.67% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 17.27 | 19.45 | -20.32 | 45.08 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.18 | 0.93 | 1.31 | 1.02 |
| Cash Conversion Cycle | 104.88 | 129.62 | 98.80 | 111.04 |